Trending...
- Independent Global Film Movement Tackles Diversity Issues At The 75th Festival De Cannes
- ONE Brands & FULFIL™ Join Forces at TheFitExpo Los Angeles
- Are You Making This Dangerous Mistake with Your Free Offer?
FAYETTEVILLE, Ark. - Californer -- Lineus Medical, after receiving FDA clearance in May 2021 for its flagship product – SafeBreak Vascular, continues to expand its distribution network into the Northeast with the signing of New England Medical Specialties. NEMS specialize in products for I.V. Therapy, vascular access, oncology, and fall prevention. Their sales team covers Vermont, New Hampshire, Massachusetts, Rhode Island, Connecticut, and New York on behalf of Lineus Medical.
"New England Medical Specialties has provided innovative medical device solutions to our customers for over 35 years." said NEMS President Bob Proietto. "We specialize in I.V. therapy and vascular access and know that SafeBreak Vascular is going to be an important part of our product portfolio. SafeBreak Vascular is an innovative product, and we are known for bringing new technologies to the marketplace."
Lineus Medical CEO, Vance Clement, added, "When partnering with medical device distributors, we work with the best. New England Medical Specialties is the leader in their area of the country, and we are thrilled to have them represent us. Our flagship product, SafeBreak Vascular, was proven to reduce IV complications requiring an IV restart by 44% in a randomized clinical study in Hartford, CT1. Having a study conducted in New England is an impactful starting point for Bob Proietto and his team."
More on The Californer
SafeBreak Vascular is a break-away connector that fits into any peripheral IV line on any standard luer lock in the world. The device is designed to separate when damaging force is placed on an IV line, reducing vein irritation and the chances of the IV dislodging. When the device separates, valves on each side of the device close to stop the flow of medication from the pump and blood flow from the patient's IV catheter. The separated SafeBreak can be replaced with a new, sterile SafeBreak and the IV restarted without the need for another needlestick for the patient.
SafeBreak Vascular reduces the failure of peripheral IV lines and the negative cascade of events that occurs when an IV restart is required. Peripheral IVs fail 46% of the time before their intended use is complete according to the clinical literature and cost the US healthcare system over $5B annually2.
ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a patented, break-away technology designed to work with all types of medical tubing. Complications with feeding tubes, IV lines, urinary catheters and other medical tubing may be reduced when a force-activated separation device is used. Learn more at www.lineusmed.com and follow us on LinkedIn or Twitter.
More on The Californer
1D.I.P.P.E.R Study - Data on file.
2Data on file.
3Helm, R.E., et al., Accepted but Unacceptable: Peripheral IV Catheter Failure. Journal of Infusion Nursing. 2015;38(3): 189-203
MKG-0122 Rev 0
"New England Medical Specialties has provided innovative medical device solutions to our customers for over 35 years." said NEMS President Bob Proietto. "We specialize in I.V. therapy and vascular access and know that SafeBreak Vascular is going to be an important part of our product portfolio. SafeBreak Vascular is an innovative product, and we are known for bringing new technologies to the marketplace."
Lineus Medical CEO, Vance Clement, added, "When partnering with medical device distributors, we work with the best. New England Medical Specialties is the leader in their area of the country, and we are thrilled to have them represent us. Our flagship product, SafeBreak Vascular, was proven to reduce IV complications requiring an IV restart by 44% in a randomized clinical study in Hartford, CT1. Having a study conducted in New England is an impactful starting point for Bob Proietto and his team."
More on The Californer
- Cabrillo EDC Empowers Ventura County Residents for Success during NeighborWorks Week
- San Jose: Affordable Housing Project Gets $54.8M from State
- Brian Peterson assisted Kaplan Tarps & Cargo Controls with obtaining a GSA Multiple Award Schedule
- Protagonist Therapeutics to Present Updated Phase 2 Rusfertide Clinical Results in Polycythemia Vera (PV) at ASCO 2022
- RH to Report First Quarter Fiscal 2022 Financial Results on June 2, 2022
SafeBreak Vascular is a break-away connector that fits into any peripheral IV line on any standard luer lock in the world. The device is designed to separate when damaging force is placed on an IV line, reducing vein irritation and the chances of the IV dislodging. When the device separates, valves on each side of the device close to stop the flow of medication from the pump and blood flow from the patient's IV catheter. The separated SafeBreak can be replaced with a new, sterile SafeBreak and the IV restarted without the need for another needlestick for the patient.
SafeBreak Vascular reduces the failure of peripheral IV lines and the negative cascade of events that occurs when an IV restart is required. Peripheral IVs fail 46% of the time before their intended use is complete according to the clinical literature and cost the US healthcare system over $5B annually2.
ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a patented, break-away technology designed to work with all types of medical tubing. Complications with feeding tubes, IV lines, urinary catheters and other medical tubing may be reduced when a force-activated separation device is used. Learn more at www.lineusmed.com and follow us on LinkedIn or Twitter.
More on The Californer
- California Distributes $108.6 Million to Create Regional Education-to-Career Pipelines
- San Francisco: Mayor London Breed Announces $50.7 Million Investment Over Two Years in Children and Family Recovery Plan in Proposed Budget
- Enry's Island Set to be the First Incubator-Accelerator to Have its Own Building in a Metaverse
- Robocorp Wins Intellyx's 2022 Digital Innovator Award
- New Bill Opens the Door for Lawsuits Against the Government Based on Contaminated Drinking Water at Camp Lejeune
1D.I.P.P.E.R Study - Data on file.
2Data on file.
3Helm, R.E., et al., Accepted but Unacceptable: Peripheral IV Catheter Failure. Journal of Infusion Nursing. 2015;38(3): 189-203
MKG-0122 Rev 0
Source: Lineus Medical
0 Comments
Latest on The Californer
- California Senate Votes to Support CARE Court, as Leading State Business Organizations Join Expanding Coalition
- CORRECTING and REPLACING CAPTION BSI Wins Best Biotech Startup Business of the Year 2022 Award
- Wigs to Create the Perfect Hairstyle for Graduation Season Are Coming
- Jessica Ross Graces the Cover of Center Stage Magazine
- PEGA Investor Alert: Robbins LLP Remind Shareholders of Class Action Against Pegasystems Inc. (PEGA)
- All-optical computation of a group of transformations using polarization-encoded diffractive network
- California: Following Texas Elementary School Shooting, Governor Newsom and Legislative Leaders to Expedite Gun Reform Legislation
- San Jose: : New Deputy City Manager to Tackle Homelessness and Quality of Life Challenges
- Long Beach: A Message on the Tragedy in Texas
- Momentus Launches First Demonstration Flight on SpaceX Falcon 9
- Harmonic to Participate in the Jefferies Software Conference
- Rising to the Challenge of the Human Experience
- San Jose: San José Affordable Housing Development Awarded $54.8 million from State
- Multi-Billion Dollar Wellness Industry is Fatally Flawed and You're Paying the Price: Here's What You Need to Know
- Up and coming POP / R&B Girl Group Releases New Music Video
- American Vanguard Calls on Cruiser Capital to Be Fully Transparent With Stockholders
- Attention All Kinds of Businesses: Is your Advertising Producing the Results you were Hoping for?
- DB Capital Acquires Denver Metro Apartment Community for $38 Million
- Planful Announces Availability of Predict: Projections and Enhancements to the Business User Experience, Extending Its Planning and Budgeting Innovations
- San Francisco: Mayor London Breed Announces New Budget Investments in Permanent Supportive Housing